Revolutionary Advances in Bone Regeneration by Novadip Biosciences
In a compelling presentation at LSI USA ’25, Dr. Denis Dufrane of Novadip Biosciences unveils groundbreaking progress in the field of regenerative medicine, specifically targeting complex bone defects. Novadip has developed a pioneering osteobiologic platform capable of addressing both small and large skeletal injuries across adult and pediatric populations. This platform not only promotes bone […]
DNA’s Hidden Helpers: How They Control Stem Cells for Healing
A study led by UC Riverside explored how adult stem cells maintain their ability to renew, a process critical for tissue repair and regeneration. Researchers discovered that helper proteins called histone chaperones are essential for properly organizing DNA and ensuring stem cells remain in their undifferentiated state. When these chaperones are disrupted, the stem cells lose their renewal capacity and begin […]
How Fucoidan from Fucus vesiculosus Boosts Stem Cell Release from Bone Marrow
Fucoidan, a natural polysaccharide from brown seaweed, notably from Fucus vesiculosus (Bladderwrack), is gaining attention for its remarkable ability to mobilize stem cells from bone marrow. This process has significant potential for regenerative health and healing. What is Fucoidan? Fucoidan is a sulfated polysaccharide found in various brown seaweeds. Its exact chemical makeup can vary, […]
Celularity and BlueSphere Bio Collaborate on Cell Therapy Manufacturing
Celularity Inc., a cellular medicine company, has entered into a collaboration agreement with BlueSphere Bio (BSB).? Celularity will leverage its manufacturing capabilities to produce BSB’s T cell receptor (TCR) T cell therapies.? This partnership will focus on manufacturing and quality control at Celularity’s New Jersey facility for BSB’s therapies, including a treatment for Acute Myelogenous […]
Longeveron: WHO Approves “Laromestrocel” for Lomecel-Bâ„¢ Stem Cell Therapy
Longeveron Inc. announced that the World Health Organization (WHO) has approved the International Non-proprietary Name (INN) “laromestrocel” for their cellular therapy Lomecel-Bâ„¢? Lomecel-Bâ„¢ is being evaluated as a treatment for Alzheimer?s disease and hypoplastic left heart syndrome (HLHS).? It is a proprietary product made from medicinal signaling cells and has received FDA designations such as […]
Genetically Engineered Stem Cells Fight Gastroesophageal Cancer
Dr. Saar Gill of the University of Pennsylvania received a $450,000 grant from the DeGregorio Family Foundation to continue research on genetically engineered stem cells to combat gastroesophageal cancer. This builds upon previous work using Chimeric Antigen Receptor (CAR) macrophages to target and destroy cancer cells within solid tumors. The ultimate goal is to develop a long-lasting supply of cancer-fighting cells. […]
GATC Health’s Stem Cell Therapy for Diabetes
GATC Health Corp. announced a groundbreaking stem cell therapy for diabetes, detailed in a recent publication in the American Journal of Biomedical Science & Research. This autologous therapy uses a patient’s own stem cells to potentially treat both Type 1 and Type 2 diabetes, offering improved blood sugar control and reduced medication dependence. The process is […]
How Stem Cell Technology is Transforming IVF
Ever wondered if there’s a way to make IVF less of a rollercoaster? Or if science could give fertility a second chance? Well, stem cell technology is stepping up to the plate, and it’s changing the game for IVF and infertility treatment. Let’s break it down—no jargon, no fluff—just the real deal on how stem cells are rewriting the […]
Reversing Aging: Professor Thomas Rando Reveals Stem Cell Secrets & Lifestyle Hacks
Unlocking the secrets of youth and regeneration, Professor Thomas Rando delves into groundbreaking insights on stem cells, aging, and the profound impacts of lifestyle interventions. This enlightening talk unveils the regenerative capabilities of muscle and other tissues, the role of epigenetics, and the remarkable rejuvenation effects of exercise and fasting. Rando’s research highlights the transformative […]
NYSCF and Janssen Partner on Neurodegenerative Disease Drug Discovery
The New York Stem Cell Foundation Research Institute (NYSCF) and Janssen Research & Development, a Johnson & Johnson company, have partnered to accelerate the development of precision medicines for neurodegenerative diseases. NYSCF’s AI-powered platform, using automated stem cell systems, will be leveraged to identify new drug targets and therapies. This collaboration combines NYSCF’s expertise in stem cell […]